TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 18461499

Group type: EXPERIMENTAL
Intervention: Exercise consultation intervention
Number of subjects: 56

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 56
Study: 16527696

Group type: EXPERIMENTAL
Intervention: BIRB 796 (10, 20, 30, or 60 mg twice daily for 8 weeks)
Number of subjects: 284

Group type: EXPERIMENTAL
Intervention: BIRB 796
Number of subjects: 284

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 284
Study: 14553957

Group type: EXPERIMENTAL
Intervention: Calcium supplementation (2 g daily)
Number of subjects: 260

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 260
Study: 10880809

Group type: EXPERIMENTAL
Intervention: Transcranial magnetic stimulation (TMS)
Number of subjects: 44
Study: 9014958

Group type: EXPERIMENTAL
Intervention: Combined NMES/TENS
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: NMES
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: TENS
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 8281733

Group type: EXPERIMENTAL
Intervention: Shortened length of initial hospital stay (9 +/- 3 days)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Long length of initial hospital stay (23 +/- 4 days)
Number of subjects: 61
Study: 2871782

Group type: EXPERIMENTAL
Intervention: 150 mg/day bevantolol
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: 300 mg/day bevantolol
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Bevantolol
Number of subjects: 107

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 107
Study: 30234576

Group type: EXPERIMENTAL
Intervention: Transcutaneous Electrical Nerve Stimulation (TENS) combined with Standard Wound Care (SWC)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Standard Wound Care (SWC)
Number of subjects: 22
Study: 27473173

Group type: EXPERIMENTAL
Intervention: PatientTIME intervention group
Number of subjects: 97

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 97
Study: 25168526

Group type: EXPERIMENTAL
Intervention: Diode laser vaporization (980 nm)
Number of subjects: 115

Group type: COMPARATOR
Intervention: Transurethral resection of the prostate (TURP)
Number of subjects: 115
Study: 23732754

Group type: EXPERIMENTAL
Intervention: Interferon beta‐1b, 250 μg, for at least 2 years
Number of subjects: 239
Study: 21097433

Group type: EXPERIMENTAL
Intervention: Intravenous parecoxib sodium (40 mg) at anesthesia induction (group A)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Intravenous parecoxib sodium (40 mg) 30 min before the completion of surgery (group B)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 40
Study: 17399824

Group type: EXPERIMENTAL
Intervention: Diastolic Heart Failure (DHF)
Number of subjects: 446

Group type: EXPERIMENTAL
Intervention: Systolic Heart Failure (SHF)
Number of subjects: 446

Group type: COMPARATOR
Intervention: Comparison of DHF and SHF
Number of subjects: 446

Group type: COMPARATOR
Intervention: ACE inhibitors and aldosterone antagonists
Number of subjects: 446
Study: 16377936

Group type: EXPERIMENTAL
Intervention: Losartan
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Amlodipine
Number of subjects: 300

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 300
Study: 14567559

Group type: EXPERIMENTAL
Intervention: IFN‐beta1b (8 million units every other day)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 11028492

Group type: EXPERIMENTAL
Intervention: Systemic thrombolytic therapy
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: High-dose thrombolysis
Number of subjects: 250

Group type: COMPARATOR
Intervention: Conventional heparin/anticoagulation therapy
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Thrombolysis (both systemic and local)
Number of subjects: 250
Study: 7647166

Group type: EXPERIMENTAL
Intervention: Arecoline at 2.1 micrograms/kg (n = 4)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Arecoline at 4.2 micrograms/kg (n = 5)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 6
Study: 2566321

Group type: EXPERIMENTAL
Intervention: Celiprolol (400 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Propranolol (40 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 324863

Group type: EXPERIMENTAL
Intervention: Aluminum hydroxide gel (AG) 15 ml
Number of subjects: 44

Group type: COMPARATOR
Intervention: Dummy gel (DG)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Aluminum hydroxide gel (AG)
Number of subjects: 44
Study: 31841818

Group type: EXPERIMENTAL
Intervention: Zinc augmentation
Number of subjects: 60

Group type: COMPARATOR
Intervention: Methylphenidate alone (Control)
Number of subjects: 60
Study: 31488115

Group type: EXPERIMENTAL
Intervention: 16-week supervised concurrent (aerobic and strength) exercise intervention program (3 sessions/week, 60 min/session)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned in the abstract)
Number of subjects: 80
Study: 27667329

Group type: EXPERIMENTAL
Intervention: Japan Diet nutritional education program for 6 weeks
Number of subjects: 33
Study: 25453742

Group type: COMPARATOR
Intervention: Wavelet phase coherence analysis (WPCO) during sit-to-stand posture change
Number of subjects: 16

Group type: COMPARATOR
Intervention: Wavelet phase coherence analysis (WPCO) during stand-to-sit posture change
Number of subjects: 16
Study: 24155938

Group type: EXPERIMENTAL
Intervention: Normoxia
Number of subjects: 10

Group type: COMPARATOR
Intervention: Acute moderate hypoxia (FIO2 0.138)
Number of subjects: 10
Study: 21139319

Group type: EXPERIMENTAL
Intervention: Health support method facilitating goal attainment (intervention group)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Instruction in exercise and health support using publicly available media (control group)
Number of subjects: 99
Study: 18772855

Group type: EXPERIMENTAL
Intervention: Low-sodium diet (20 mEq/day)
Number of subjects: 200
Study: 16425130

Group type: EXPERIMENTAL
Intervention: O157-rEPA vaccine (1 or 2 doses)
Number of subjects: 49
Study: 12867304

Group type: EXPERIMENTAL
Intervention: 200 J biphasic shocks
Number of subjects: 1129

Group type: EXPERIMENTAL
Intervention: 115-130 J biphasic shocks
Number of subjects: 1129

Group type: COMPARATOR
Intervention: Higher energy monophasic shocks
Number of subjects: 1129
Study: 14635316

Group type: EXPERIMENTAL
Intervention: Weight reduction treatment
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Weight reduction and electrotherapy modalities
Number of subjects: 126

Group type: COMPARATOR
Intervention: Electrotherapy modalities to relieve pain
Number of subjects: 126
Study: 9129465

Group type: COMPARATOR
Intervention: Fat-free soup (control)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Fat-free soup with olestra (33.3 g)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: High-fat soup (33.3 g fat)
Number of subjects: 67
Study: 8230574

Group type: EXPERIMENTAL
Intervention: Isovolemic hemodilution to a hematocrit of 28%
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control group (no hemodilution)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Isovolemic hemodilution
Number of subjects: 39
Study: 3023276

Group type: EXPERIMENTAL
Intervention: Propranolol (80 mg three times daily)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo (lactose)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 11
Study: 31277298

Group type: EXPERIMENTAL
Intervention: Boys living in a school dormitory, participating in sports teams, exercising on a wet floor, rebellious behavior, and having longer PA exposure time
Number of subjects: 1270

Group type: EXPERIMENTAL
Intervention: Girls who were sports team members, whose parents were divorced or separated, and those with longer PA exposure time
Number of subjects: 1270

Group type: EXPERIMENTAL
Intervention: Overall injury incidence
Number of subjects: 1270

Group type: EXPERIMENTAL
Intervention: Injury risk
Number of subjects: 1270

Group type: EXPERIMENTAL
Intervention: Injury rate
Number of subjects: 1270
Study: 29398254

Group type: EXPERIMENTAL
Intervention: Sleeve Gastrectomy (SG)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Intensive Lifestyle Modification + Liraglutide (ILM+liraglutide)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Intensive Lifestyle Modification (ILM)
Number of subjects: 75
Study: 27676671

Group type: EXPERIMENTAL
Intervention: 2.5 mL contrast dye
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: 5.0 mL contrast dye
Number of subjects: 70
Study: 24919095

Group type: EXPERIMENTAL
Intervention: Sit 'N' Fit Chair Yoga
Number of subjects: 0

Group type: COMPARATOR
Intervention: Attention control group
Number of subjects: 0
Study: 23111427

Group type: EXPERIMENTAL
Intervention: Oscillating radial optic flow
Number of subjects: 0

Group type: COMPARATOR
Intervention: Smooth radial optic flow
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Microgravity exposure
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Post-flight vection sensitivity
Number of subjects: 0

Group type: COMPARATOR
Intervention: 1-g vection responses
Number of subjects: 0
Study: 20193857

Group type: EXPERIMENTAL
Intervention: Wrist arthroscopy for treatment and evaluation of scaphoid fracture and associated carpal injuries
Number of subjects: 40
Study: 18581957

Group type: EXPERIMENTAL
Intervention: Complete decongestive physiotherapy (CDP) 60 min
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Complete decongestive physiotherapy (CDP) 30 min plus intermittent pneumatic compression (IPC) 30 min
Number of subjects: 24
Study: 15820849

Group type: EXPERIMENTAL
Intervention: Preoperative self-distraction coping
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Emotional support
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Religious-based coping
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Preoperative distress
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Behavioral disengagement
Number of subjects: 122
Study: 11807347

Group type: EXPERIMENTAL
Intervention: Nerve and tendon gliding exercises with splint treatment
Number of subjects: 28

Group type: COMPARATOR
Intervention: Splint treatment only
Number of subjects: 28
Study: 10198656

Group type: EXPERIMENTAL
Intervention: $10 cash
Number of subjects: 1078

Group type: EXPERIMENTAL
Intervention: Grocery store coupons
Number of subjects: 1078

Group type: EXPERIMENTAL
Intervention: Bus tokens/fast-food coupons
Number of subjects: 1078

Group type: EXPERIMENTAL
Intervention: Motivational education
Number of subjects: 1078

Group type: COMPARATOR
Intervention: Usual encouragement
Number of subjects: 1078
Study: 7572539

Group type: EXPERIMENTAL
Intervention: Immunotherapy (IT)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 31
Study: 1656818

Group type: EXPERIMENTAL
Intervention: Ascorbic acid 1 g in 500 ml of 5% glucose (Group B)
Number of subjects: 16

Group type: COMPARATOR
Intervention: 500 ml of 5% glucose (Group A)
Number of subjects: 16
Study: 6399302

Group type: EXPERIMENTAL
Intervention: Ceftazidime
Number of subjects: 20

Group type: COMPARATOR
Intervention: Amikacin
Number of subjects: 20
Study: 31226960

Group type: EXPERIMENTAL
Intervention: Robot-assisted esophagectomy (RAE)
Number of subjects: 360

Group type: COMPARATOR
Intervention: Conventional minimally invasive esophagectomy (MIE)
Number of subjects: 360
Study: 29702118

Group type: EXPERIMENTAL
Intervention: Minimal therapist contact Cognitive Behavior Therapy (MC-CBT)
Number of subjects: 436

Group type: COMPARATOR
Intervention: Education (EDU)
Number of subjects: 436

Group type: COMPARATOR
Intervention: Standard Cognitive Behavior Therapy (S-CBT)
Number of subjects: 436

Group type: EXPERIMENTAL
Intervention: Cognitive Behavior Therapy (CBT)
Number of subjects: 436
Study: 26692119

Group type: EXPERIMENTAL
Intervention: Tolvaptan (TLV) plus conventional treatment, n=26
Number of subjects: 52

Group type: COMPARATOR
Intervention: Furosemide (FRM) increased dosage, n=26
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Tolvaptan (TLV)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Furosemide (FRM) increased dosage
Number of subjects: 52
Study: 25430726

Group type: EXPERIMENTAL
Intervention: Mass drug administration (MDA) with praziquantel
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional models (Poisson and negative binomial)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Zero modified models (zero inflated Poisson and zero inflated negative binomial)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hurdle models (Poisson logit hurdle and negative binomial logit hurdle)
Number of subjects: 0
Study: 23134162

Group type: EXPERIMENTAL
Intervention: Jet ventilation catheter
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Intravenous catheter
Number of subjects: 32

Group type: COMPARATOR
Intervention: Emergency tracheotomy
Number of subjects: 32
Study: 19808950

Group type: EXPERIMENTAL
Intervention: Atorvastatin 20 mg per day
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg per day
Number of subjects: 40
Study: 18423560

Group type: EXPERIMENTAL
Intervention: Bevacizumab plus erlotinib
Number of subjects: 13
Study: 15722489

Group type: EXPERIMENTAL
Intervention: Identification of IPV victims and referral to community resources
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Double-blind randomized controlled trial
Number of subjects: 0
Study: 12023696

Group type: EXPERIMENTAL
Intervention: Diltiazem
Number of subjects: 10881

Group type: COMPARATOR
Intervention: Conventional treatment (diuretic/beta-blocker)
Number of subjects: 10881
Study: 10366118

Group type: EXPERIMENTAL
Intervention: Alendronate 5 mg/day for 2 years followed by 10 mg/day for 12-30 months
Number of subjects: 2984

Group type: EXPERIMENTAL
Intervention: Alendronate treatment
Number of subjects: 2984
Study: 7863988

Group type: EXPERIMENTAL
Intervention: Pravastatin
Number of subjects: 151
Study: 1784888

Group type: EXPERIMENTAL
Intervention: S-ibuprofen (400 mg T.I.D.)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Racemic ibuprofen (600 mg T.I.D.)
Number of subjects: 50
Study: 7008642

Group type: EXPERIMENTAL
Intervention: Inhaled salbutamol powder (0.2 mg/dosis)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Inhaled salbutamol spray (0.1 mg/dosis)
Number of subjects: 43
Study: 31513164

Group type: EXPERIMENTAL
Intervention: Interstitial electrostimulation (IES)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Cutaneous electrostimulation (control)
Number of subjects: 64
Study: 27979034

Group type: EXPERIMENTAL
Intervention: Percutaneous LAA occlusion
Number of subjects: 396

Group type: COMPARATOR
Intervention: Novel oral anticoagulants (NOAC)
Number of subjects: 396
Study: 25458910

Group type: EXPERIMENTAL
Intervention: Azithromycin treatment for 14 days
Number of subjects: 40
Study: 23203904

Group type: EXPERIMENTAL
Intervention: Nintendo-Wii Bowling, 60 min/twice a week for 6 weeks
Number of subjects: 27
Study: 22741442

Group type: EXPERIMENTAL
Intervention: Tamoxifen 10 mg bid + VitE 100 mg tid
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Levocarnitine oral solution 1 bottle bid + VitE 100 mg tid
Number of subjects: 106

Group type: COMPARATOR
Intervention: Tamoxifen 10 mg bid
Number of subjects: 106

Group type: COMPARATOR
Intervention: Levocarnitine oral solution 1 bottle bid
Number of subjects: 106
Study: 19931288

Group type: EXPERIMENTAL
Intervention: Caffeine 250 mg (paired group)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo (unpaired group)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Caffeine 250 mg (Experiment 2)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo (Experiment 2)
Number of subjects: 28
Study: 17922944

Group type: EXPERIMENTAL
Intervention: Fresh yoghurt
Number of subjects: 33

Group type: COMPARATOR
Intervention: Pasteurised yoghurt
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Lactose intolerance status
Number of subjects: 33
Study: 15797063

Group type: EXPERIMENTAL
Intervention: Sorin Slimline valve prosthesis
Number of subjects: 80

Group type: COMPARATOR
Intervention: St. Jude High Performance valve prosthesis
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Both valves
Number of subjects: 80
Study: 12536346

Group type: EXPERIMENTAL
Intervention: Maternal vitamin K2 supplementation (15 mg/d Menatetrenone since the 14th day after parturition)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Control group (without maternal supplementation)
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Maternal vitamin K2 supplementation
Number of subjects: 77
Study: 9824933

Group type: EXPERIMENTAL
Intervention: Octreotide 0.1 cc (100 mcg) three times daily subcutaneously for the first seven days post-operatively
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control group (no Octreotide)
Number of subjects: 34
Study: 7988247

Group type: EXPERIMENTAL
Intervention: Postoperative combined chemotherapy with cyclophosphamide, doxorubicin, and cisplatin (CAP)
Number of subjects: 141

Group type: COMPARATOR
Intervention: Bacillus Calmette‐Guerin (BCG) and levamisole immunotherapy
Number of subjects: 141
Study: 3185461

Group type: EXPERIMENTAL
Intervention: Caffeine (400 mg per os)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 29400626

Group type: EXPERIMENTAL
Intervention: Aerobic exercise (n=5)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Folinic acid (5 mg daily for 4 weeks, n=6)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo (n=5)
Number of subjects: 16
Study: 27275104

Group type: EXPERIMENTAL
Intervention: Naproxen (500 mg)
Number of subjects: 324

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 324
Study: 26276750

Group type: EXPERIMENTAL
Intervention: Soy supplementation (50 mg isoflavones per day; n = 46)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Placebo (n = 49)
Number of subjects: 95
Study: 23751235

Group type: EXPERIMENTAL
Intervention: Placebo spray with suggestion to increase BP
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Placebo spray with suggestion to decrease BP
Number of subjects: 92

Group type: COMPARATOR
Intervention: Placebo spray with no suggestion (controls)
Number of subjects: 92
Study: 20647234

Group type: EXPERIMENTAL
Intervention: Enhanced Web site (interactive with detailed, personalized timeline)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Standard Web site
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Enhanced Web site
Number of subjects: 64
Study: 18981703

Group type: EXPERIMENTAL
Intervention: Indomethacin film with 2% IM and 10% EC
Number of subjects: 0

Group type: COMPARATOR
Intervention: Indomethacin film with no EC
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Indomethacin film with 10% EC
Number of subjects: 0

Group type: COMPARATOR
Intervention: Indomethacin film with carboxyvinyl polymer
Number of subjects: 0
Study: 15932725

Group type: EXPERIMENTAL
Intervention: Azathioprine (AzA) treatment after conversion from mycophenolate mofetil (MMF), n = 42
Number of subjects: 87

Group type: COMPARATOR
Intervention: Continued mycophenolate mofetil (MMF) treatment, n = 45
Number of subjects: 87
Study: 12667396

Group type: EXPERIMENTAL
Intervention: Peripancreatic arterial ligation and arterial infusion regional chemotherapy (Group B)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Systemic chemotherapy after surgery (Group A)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 29
Study: 10373082

Group type: EXPERIMENTAL
Intervention: Oxalic acid total etch technique
Number of subjects: 52

Group type: COMPARATOR
Intervention: Phosphoric acid enamel etch
Number of subjects: 52
Study: 8779014

Group type: EXPERIMENTAL
Intervention: Polymethylmethacrylate
Number of subjects: 81

Group type: COMPARATOR
Intervention: Discectomy only
Number of subjects: 81
Study: 1839435

Group type: EXPERIMENTAL
Intervention: Amlodipine (5 mg/day, adjustable to 10 mg/day after 4 weeks)
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Amlodipine
Number of subjects: 320
Study: 6133287

Group type: EXPERIMENTAL
Intervention: Clopenthixol decanoate (100 mg 4-weekly to 400 mg 2-weekly)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Fluphenazine decanoate (12.5 mg 4-weekly to 37.5 mg 3-weekly)
Number of subjects: 45
Study: 31052212

Group type: EXPERIMENTAL
Intervention: Natural wine
Number of subjects: 55

Group type: COMPARATOR
Intervention: Conventional wine
Number of subjects: 55
Study: 29895500

Group type: EXPERIMENTAL
Intervention: 600L Euvichol® (Test)
Number of subjects: 442

Group type: COMPARATOR
Intervention: 100L Euvichol® (Comparator)
Number of subjects: 442
Study: 26153513

Group type: EXPERIMENTAL
Intervention: Anastrozole (5 years)
Number of subjects: 330
Study: 24479893

Group type: EXPERIMENTAL
Intervention: Nurse-led individualised education programme to promote self-care of sleep-activity, including physical training, relaxation exercise, and a CD-based relaxation programme.
Number of subjects: 47

Group type: COMPARATOR
Intervention: Control group received a brochure about sleep and stress.
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Nurse-led individualised education programme.
Number of subjects: 47

Group type: COMPARATOR
Intervention: Control group.
Number of subjects: 47
Study: 23138830

Group type: EXPERIMENTAL
Intervention: Wand computer-controlled local anaesthesia
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional technique
Number of subjects: 30
Study: 20117262

Group type: EXPERIMENTAL
Intervention: Vaxfectin-adjuvanted monovalent plasmid DNA vaccine
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Vaxfectin-adjuvanted trivalent plasmid DNA vaccine
Number of subjects: 103

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 103
Study: 17585668

Group type: EXPERIMENTAL
Intervention: Needling method for harmonizing spleen-stomach, treated twice each day for 10 days
Number of subjects: 72

Group type: COMPARATOR
Intervention: Motilium 10 mg, oral administration 3 times each day, 30 min before meals
Number of subjects: 72
Study: 14691696

Group type: EXPERIMENTAL
Intervention: Laparoscopic appendectomy
Number of subjects: 52

Group type: COMPARATOR
Intervention: Open appendectomy
Number of subjects: 52
Study: 12364420

Group type: EXPERIMENTAL
Intervention: Serum estradiol
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Serum OPG
Number of subjects: 180

Group type: COMPARATOR
Intervention: Urine markers of bone resorption
Number of subjects: 180
Study: 9660911

Group type: EXPERIMENTAL
Intervention: Toronto Stentless Porcine Valve (SPV)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Carpentier‐Edwards SAV stented bioprosthesis
Number of subjects: 112